Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who started this subject	2/5/2003 2:57:32 PM
From: tuck	Read Replies (1) of 684

ARDM now selling for less than last reported cash. That figure is a bit stale, and the situation may no longer obtain once the 1Q03 PR comes out. I can't think of any particular reason to buy right now; I'm not aware (caveat emptor) of any material news flow for a good while -- as in many months. ABGX, similar boat. Haven't checked the convert/debt situation with either of these. ABGX does have some news coming this quarter; ABX-CBL for GVHD. Addresses a smaller market size than ABX-EGF, but still has potential to move the stock a bit, I would think. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next